![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Vol. 14, Issue 11, 4376-4386, November 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* Stanford University School of Medicine, Stanford, California, 94305-5151;
Norwegian Radium Hospital, 0310 Oslo, Norway; and
University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6055
Submitted May 6, 2003;
Revised July 16, 2003;
Accepted July 23, 2003
Monitoring Editor: Pamela Silver
We used DNA microarrays to characterize the global gene expression patterns in surface epithelial cancers of the ovary. We identified groups of genes that distinguished the clear cell subtype from other ovarian carcinomas, grade I and II from grade III serous papillary carcinomas, and ovarian from breast carcinomas. Six clear cell carcinomas were distinguished from 36 other ovarian carcinomas (predominantly serous papillary) based on their gene expression patterns. The differences may yield insights into the worse prognosis and therapeutic resistance associated with clear cell carcinomas. A comparison of the gene expression patterns in the ovarian cancers to published data of gene expression in breast cancers revealed a large number of differentially expressed genes. We identified a group of 62 genes that correctly classified all 125 breast and ovarian cancer specimens. Among the best discriminators more highly expressed in the ovarian carcinomas were PAX8 (paired box gene 8), mesothelin, and ephrin-B1 (EFNB1). Although estrogen receptor was expressed in both the ovarian and breast cancers, genes that are coregulated with the estrogen receptor in breast cancers, including GATA-3, LIV-1, and X-box binding protein 1, did not show a similar pattern of coexpression in the ovarian cancers.
P.O.B. is an Investigator of the Howard Hughes Medical Institute. || Corresponding author. E-mail address: brandy{at}stanford.edu.
This article has been cited by other articles:
|
|
 |
|
  M. S. Anglesio, J. M. Arnold, J. George, A. V. Tinker, R. Tothill, N. Waddell, L. Simms, B. Locandro, S. Fereday, N. Traficante, et al. Mutation of ERBB2 Provides a Novel Alternative Mechanism for the Ubiquitous Activation of RAS-MAPK in Ovarian Serous Low Malignant Potential Tumors Mol. Cancer Res., November 1, 2008; 6(11): 1678 - 1690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Tothill, A. V. Tinker, J. George, R. Brown, S. B. Fox, S. Lade, D. S. Johnson, M. K. Trivett, D. Etemadmoghadam, B. Locandro, et al. Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome Clin. Cancer Res., August 15, 2008; 14(16): 5198 - 5208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Jiang, T. Freywald, J. Webster, D. Kozan, R. Geyer, J. DeCoteau, A. Narendran, and A. Freywald In Human Leukemia Cells Ephrin-B-Induced Invasive Activity Is Supported by Lck and Is Associated with Reassembling of Lipid Raft Signaling Complexes Mol. Cancer Res., February 1, 2008; 6(2): 291 - 305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. G. Leong, K. Niessen, I. Kulic, A. Raouf, C. Eaves, I. Pollet, and A. Karsan Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin J. Exp. Med., November 26, 2007; 204(12): 2935 - 2948. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Singer, N. D. Socci, G. Ambrosini, E. Sambol, P. Decarolis, Y. Wu, R. O'Connor, R. Maki, A. Viale, C. Sander, et al. Gene Expression Profiling of Liposarcoma Identifies Distinct Biological Types/Subtypes and Potential Therapeutic Targets in Well-Differentiated and Dedifferentiated Liposarcoma Cancer Res., July 15, 2007; 67(14): 6626 - 6636. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Shell, S.-M. Park, A. R. Radjabi, R. Schickel, E. O. Kistner, D. A. Jewell, C. Feig, E. Lengyel, and M. E. Peter Let-7 expression defines two differentiation stages of cancer PNAS, July 3, 2007; 104(27): 11400 - 11405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. K. Dressman, A. Berchuck, G. Chan, J. Zhai, A. Bild, R. Sayer, J. Cragun, J. Clarke, R. S. Whitaker, L. Li, et al. An Integrated Genomic-Based Approach to Individualized Treatment of Patients With Advanced-Stage Ovarian Cancer J. Clin. Oncol., February 10, 2007; 25(5): 517 - 525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Castellano, J. F. Reid, P. Alberti, M. L. Carcangiu, A. Tomassetti, and S. Canevari New Potential Ligand-Receptor Signaling Loops in Ovarian Cancer Identified in Multiple Gene Expression Studies Cancer Res., November 15, 2006; 66(22): 10709 - 10719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Choudhary, M. Brun, J. Hua, J. Lowey, E. Suh, and E. R. Dougherty Genetic test bed for feature selection Bioinformatics, April 1, 2006; 22(7): 837 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Yen, C.-Y. Hsu, T.-L. Mao, T-C. Wu, R. Roden, T.-L. Wang, and I.-M. Shih Diffuse Mesothelin Expression Correlates with Prolonged Patient Survival in Ovarian Serous Carcinoma Clin. Cancer Res., February 1, 2006; 12(3): 827 - 831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wang, R. Wu, K. R. Cho, K. A. Shedden, T. J. Barder, and D. M. Lubman Classification of Cancer Cell Lines Using an Automated Two-dimensional Liquid Mapping Method with Hierarchical Clustering Techniques Mol. Cell. Proteomics, January 1, 2006; 5(1): 43 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wang, H. Zhao, Q. Xu, W. Jin, C. Liu, H. Zhang, Z. Huang, X. Zhang, Y. Zhang, D. Xin, et al. HPtaa database-potential target genes for clinical diagnosis and immunotherapy of human carcinoma Nucleic Acids Res., January 1, 2006; 34(suppl_1): D607 - D612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Lambert, E. M. Curran, B. M. Judy, G. N. Milligan, D. B. Lubahn, and D. M. Estes Estrogen Receptor {alpha} (ER{alpha}) Deficiency in Macrophages Results in Increased Stimulation of CD4+ T Cells while 17{beta}-Estradiol Acts through ER{alpha} to Increase IL-4 and GATA-3 Expression in CD4+ T Cells Independent of Antigen Presentation J. Immunol., November 1, 2005; 175(9): 5716 - 5723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Zorn, T. Bonome, L. Gangi, G. V.R. Chandramouli, C. S. Awtrey, G. J. Gardner, J. C. Barrett, J. Boyd, and M. J. Birrer Gene Expression Profiles of Serous, Endometrioid, and Clear Cell Subtypes of Ovarian and Endometrial Cancer Clin. Cancer Res., September 15, 2005; 11(18): 6422 - 6430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Okamoto, T. Nikaido, K. Ochiai, S. Takakura, M. Saito, Y. Aoki, N. Ishii, N. Yanaihara, K. Yamada, O. Takikawa, et al. Indoleamine 2,3-Dioxygenase Serves as a Marker of Poor Prognosis in Gene Expression Profiles of Serous Ovarian Cancer Cells Clin. Cancer Res., August 15, 2005; 11(16): 6030 - 6039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. W. Cheng, J. P. Lahad, J. W. Gray, and G. B. Mills Emerging Role of RAB GTPases in Cancer and Human Disease Cancer Res., April 1, 2005; 65(7): 2516 - 2519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Drapkin, H. H. von Horsten, Y. Lin, S. C. Mok, C. P. Crum, W. R. Welch, and J. L. Hecht Human Epididymis Protein 4 (HE4) Is a Secreted Glycoprotein that Is Overexpressed by Serous and Endometrioid Ovarian Carcinomas Cancer Res., March 15, 2005; 65(6): 2162 - 2169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Bertucci, P. Finetti, J. Rougemont, E. Charafe-Jauffret, N. Cervera, C. Tarpin, C. Nguyen, L. Xerri, R. Houlgatte, J. Jacquemier, et al. Gene Expression Profiling Identifies Molecular Subtypes of Inflammatory Breast Cancer Cancer Res., March 15, 2005; 65(6): 2170 - 2178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. C. Hartmann, K. H. Lu, G. P. Linette, W. A. Cliby, K. R. Kalli, D. Gershenson, R. C. Bast, J. Stec, N. Iartchouk, D. I. Smith, et al. Gene Expression Profiles Predict Early Relapse in Ovarian Cancer after Platinum-Paclitaxel Chemotherapy Clin. Cancer Res., March 15, 2005; 11(6): 2149 - 2155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhang, N. Yang, J. Huang, R. J. Buckanovich, S. Liang, A. Barchetti, C. Vezzani, A. O'Brien-Jenkins, J. Wang, M. R. Ward, et al. Transcriptional Coactivator Drosophila Eyes Absent Homologue 2 Is Up-Regulated in Epithelial Ovarian Cancer and Promotes Tumor Growth Cancer Res., February 1, 2005; 65(3): 925 - 932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Rhodes, J. Yu, K. Shanker, N. Deshpande, R. Varambally, D. Ghosh, T. Barrette, A. Pandey, and A. M. Chinnaiyan Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression PNAS, June 22, 2004; 101(25): 9309 - 9314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. BOTSTEIN Genomic Perspective and Cancer Cold Spring Harb Symp Quant Biol, January 1, 2003; 68(0): 417 - 424. [Abstract] [PDF]
|
|
